• Contact us
  • Advertise with us
  • Login
Tashi Pharma
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • All
    • EDQM
    • EMA
    • European Commision
    • Health Canada
    • Medsafe
    • MHRA
    • SAHPRA
    • US FDA
    FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

    FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

    Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

    US FDA publishes guidance on Initiation of Voluntary Recalls

    EMA publishes Q & A for Bootstrap methodology for f2 similarity factor

    EMA publishes Q & A on Bootstrap methodology for f2 similarity factor

    US FDA publishes product-specific guidances to facilitate generic drug development

    US FDA publishes product-specific guidances to facilitate generic drug development

    Clinical Trials Regulation comes into effect in the EU

    New Clinical Trials Regulation comes into effect in the EU

    Reflection paper Forecasting demand for medicinal products in the EU_EEA

    EMA publishes reflection paper on forecasting demand for medicinal products in the EU/EEA

    Trending Tags

    • Pharma
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • Clinical
    • bioanalytical
  • Webinar
No Result
View All Result
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • All
    • EDQM
    • EMA
    • European Commision
    • Health Canada
    • Medsafe
    • MHRA
    • SAHPRA
    • US FDA
    FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

    FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

    Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

    US FDA publishes guidance on Initiation of Voluntary Recalls

    EMA publishes Q & A for Bootstrap methodology for f2 similarity factor

    EMA publishes Q & A on Bootstrap methodology for f2 similarity factor

    US FDA publishes product-specific guidances to facilitate generic drug development

    US FDA publishes product-specific guidances to facilitate generic drug development

    Clinical Trials Regulation comes into effect in the EU

    New Clinical Trials Regulation comes into effect in the EU

    Reflection paper Forecasting demand for medicinal products in the EU_EEA

    EMA publishes reflection paper on forecasting demand for medicinal products in the EU/EEA

    Trending Tags

    • Pharma
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • Clinical
    • bioanalytical
  • Webinar
No Result
View All Result
No Result
View All Result
Home Articles

Digitalisation in Healthcare – Role of Artificial Intelligence and Big Data

By Nikhil Nadarkhani

PRN by PRN
April 4, 2021
in Articles
108 3
0
Digitalisation in Healthcare – Role of Artificial Intelligence and Big Data
71
SHARES
170
VIEWS

Globally Healthcare system has seen many reforms over the past few years, changes have been witnessed in public as well as private sector. Landscape of healthcare is evolving continuously; industry experts are looking forward to having a value-based care model. New technologies are playing a key role in fulfilling the value-based care model, this model will not only lower the treatment cost but also increase the adherence to chronic therapies. Innovative ways are explored by healthcare system to reach out to patients and provide quality of life. Virtual care is today’s discussion and tomorrow’s real-life scenario same as few years back tele-medicine. As per the axis of responsible innovation, Today Healthcare industry is exploring the possible pros and cons while implementing virtual care (Figure. 1). Virtual care is in conversation at various levels, and it will be the future of healthcare.

Figure – 1

Adoption to the new technology is always a challenge. Situations make things roll out quickly, like in the COVID 19 most of the communication is virtual, worldwide health care physicians are addressing the queries of the patients virtually. Mobile Apps and programs run based on Artificial Intelligence do the diagnosis of the possible disease condition. Today technology enable individual to stay updated with his/her own health condition, wearable devices like FitBit and smart watches gives the fitness status of individual every hour. Virtual care is the integration of physiological condition of the person seeking the aid, disease condition and algorithm to advise way forward, its way more than just a video call and telemedicine. In a digital age, patients are much less dependent on their doctors for advice, increasingly able and willing to take greater control of their own health. (Champagne D., et.al, 2015)

Clinical advice offered through the system or application is a designed protocol made possible because of various database and lots of interviews with clinicians, researchers and patients. It helps in arriving on conclusion and system able to give a response within no time limit. Virtual care helps in connecting patient with clinic in no time. Everybody everywhere is adopting to this new virtual treatment options, Virtual care is fulfilling the existing need of the market.

Amazon is developing an application in this area, Amazon’s Echo, it is an Audio-Visual application to monitor health condition at home (Figure-2), still it’s in trial basis needed many of approvals

 

Figure- 2

Amazon’s Echo featured to monitor the medication log to see the adherence to therapy, it also gives information about medicines like side effects, adverse effect and dose of medicine. Echo has patented technology which monitors blood pressure and heart rate with the help of the camera. Amazon also has an Alexa; it is a platform which shows optimum mix of various healthcare application from various healthcare providers such as a Mayo clinic. It can answer various medical questions, keep records, and send SOS on emergency situations which will help in emergency conditions. Amazon is trying best to integrate Alexa and Echo model in reaching out to masses and utilising these spaces in the healthcare optimally.

Virtual care is a forward thinking in healthcare, it connects existing healthcare framework and elevate the overall experience of the patient. medication management services can improve care and reduce total health care costs. (Schnur E.S. et.al, 2014).

“virtual healthcare” as a new term to reflect the integration of rapidly diversifying uses and forms of technology that focus specifically on the ‘care component’ of healthcare. (Wilson, L. et.al, 2016). Virtual Clinics are safe, effective and provide convenience to the users. The primary challenge which needs to be overcome is public-private partnership in this area which will fetch results soon and it need to start the first virtual clinic with all approvals and further it can be scale up to other locations too.

As per the dimension of responsible innovation, four integrated dimensions like anticipation, reflexivity, inclusion, and responsiveness can be evaluated (Figure- 3)

Figure-3

GP at hand is one of the virtual platforms in London, Babylon Health has partnered with a primary care organisation in London to provide NHS services through its app and a local clinic. (Best, J., 2020.) New private sector partners coming to the forward, including telcos, training institutes, life science firms and multinational provider chains (Box, A., 2020) The GP at Hand is disruptive, it is bringing paradigm shift in today’s model of healthcare and bridging the relation of patient and doctor to next level

Full spectrum of virtual care is still hard to predict, but the transformation is on its way and complete healthcare/Life science industry will be affected with that.

(Author of the article is Nikhil Nadarkhani, a pharmaceutical brand management & marketing professional. The views expressed in the article are solely those of the author in his private capacity)

Reference:

Best, J., 2020. Doctor Apps Vs The NHS: Are Virtual Gps Kill Or Cure For The Health Service? | Zdnet., viewed 29 May 2020, < ZDNet. Available at: <https://www.zdnet.com/article/doctor-apps-vs-the-nhs-are-virtual-gps-kill-or-cure-for-the-health-service/>

Box, A., 2020. Public Private Partnerships For Universal Healthcare. [online] KPMG. Viewed 29 May 2020 <https://home.kpmg/au/en/home/insights/2017/09/the-triple-win-rethinking-public-private-partnerships-for-universal-healthcare.htm

Champagne, D., Hung, A. and Leclerc, O., 2015. The road to digital success in pharma. McKinsey White Paper.

de Almeida Costa, C., dos Santos, W.M., Neto, A.F.M., Lins, H.S., Vieira, S.J.F. and Gomez, D.E.E., 2017. PPSUS: Use of technology of information in primary care through the virtual mobile clinic system in the State of Amazonas. Journal of the International Society for Telemedicine and eHealth, 5, pp.GKR-e16.

Jennings, A., Powell, J., Armstrong, N., Sturt, J. and Dale, J., 2009. A virtual clinic for diabetes self-management: pilot study. Journal of Medical Internet Research, 11(1), p.e10.

SBS Your Language. 2020. Indian Medical Association Launches Virtual Clinic In Australia To Support The Community. viewed 29 May 2020 <https://www.sbs.com.au/language/english/indian-medical-association-launches-virtual-clinic-in-australia-to-support-the-community>

Schnur, E.S., Adams, A.J., Klepser, D.G., Doucette, W.R. and Scott, D.M., 2014. PCMHs, ACOs, and medication management: lessons learned from early research partnerships. Journal of Managed Care Pharmacy, 20(2), pp.201-205.

Wilson, L., Kim, A. and Szeto, D., 2016. A Conceptual Categorization of rapidly diversifying virtual health care initiatives in the united states today. Value in Health, 19(3), pp.A293-A294.

Previous Post

ABBOTT’S BinaxNOW COVID-19 Self Test receives US FDA emergency use authorisation

Next Post

Daiichi Sankyo Announces New 5-year Business Plan

PRN

PRN

Related Posts

environment start up
Articles

Startups Making Environment More Sustainable

by PRN
June 5, 2021
PharmEasy
Articles

PharmEasy – the online pharmacy start-up

by PRN
June 2, 2021
Mind Over Medicine
Articles

Mind Over Medicine

by PRN
May 29, 2021
MOST INNOVATIVE BIOTECH STARTUPS TO LOOK FORWARD TO IN 2021
Articles

MOST INNOVATIVE BIOTECH STARTUPS TO LOOK FORWARD IN 2021

by PRN
May 25, 2021
Sharvil Patel - Driving the next growth phase of Zydus
Articles

Sharvil Patel – Driving the next growth phase of Zydus

by PRN
May 22, 2021
Next Post
Daiichi Sankyo and AstraZeneca initiates global phase 2 trial of ENHERTU® (trastuzumab deruxtecan) in patients with HER2 mutated metastatic non-small cell lung cancer

Daiichi Sankyo Announces New 5-year Business Plan

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

Zydus to launch Oxemia

Zydus to launch Oxemia (Desidustat) a treatment for Anemia in patients with Chronic Kidney Disease (CKD)

March 7, 2022
FDA Urges Companies to be 'Recall Ready’ to Protect Public Health as Part of Final Guidance for Voluntary Recalls

US FDA Urges Companies to be ’Recall Ready’ to Protect Public Health

March 6, 2022
FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

March 5, 2022
Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

US FDA publishes guidance on Initiation of Voluntary Recalls

March 5, 2022
Kilitch Drugs Commences Rs. 100 Crore New Facility Expansion Plan

Kilitch Drugs Commences Rs. 100 Crore New Facility Expansion Plan

March 5, 2022

Browse by Category

  • Articles
  • Company Focus
  • EDQM
  • EMA
  • European Commision
  • Global Pharma News
  • Guideline News
  • Health Canada
  • Indian Pharma News
  • Interview
  • Medsafe
  • MHRA
  • SAHPRA
  • US FDA
  • Webinar

Browse by Tags

Abbott Alembic alkem Amgen Amneal AstraZeneca bayer biocon Biogen BioNTech Bristol Myers Squibb cipla covid Daiichi Sankyo drreddy Eli Lilly fda Gilead glenmark gsk Incyte Janssen Jubilant lupin MHRA Moderna Natco Novartis Novavax novo nordisk oncology Panacea Biotech Pfizer pharmacy Pharma News Pharmareg News Remdesivir roche sanofi Sun pharma Teva usfda Vaccine Viatris zydus

Contact us

Address:Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002.
Phone:+91 8511586232, +91 9029066605
Email:author@pharmaregnews.com

Browse by Tag

Abbott Alembic alkem Amgen Amneal AstraZeneca bayer biocon Biogen BioNTech Bristol Myers Squibb cipla covid Daiichi Sankyo drreddy Eli Lilly fda Gilead glenmark gsk Incyte Janssen Jubilant lupin MHRA Moderna Natco Novartis Novavax novo nordisk oncology Panacea Biotech Pfizer pharmacy Pharma News Pharmareg News Remdesivir roche sanofi Sun pharma Teva usfda Vaccine Viatris zydus

Advertise with us

© 2021 - Pharmaregnews.com. Developed by YESWEUS.

No Result
View All Result
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • bioanalytical
    • Clinical
  • Webinar
  • Contact us
  • Advertise with us
  • Login

© 2021 - Pharmaregnews.com. Developed by YESWEUS.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?